MoonLake Immunotherapeutics' Sonelokimab's Phase 3 trials, PsA market growth, and Merck's $3B bid showcase potential. Read my ...

The latest addition to The Woodlands’ life sciences core is open for business, and it could attract more businesses to the ...

Kura Oncology won FDA priority review for its drug the day before announcing new data at ASCO 2025 showing remission in about ...

Groundbreaking results from AstraZeneca’s Phase III SERENA-6 trial reveal a significant leap forward in the treatment of ...

While vepdegestrant outperformed a standard treatment option in a subtype of patients, the benefit on progression-free ...